Genome-wide transcriptome profiling of human trabecular meshwork cells treated with TGF-β2
Simpson, D. A.
Willoughby, C. E.
AffiliationGenomic Medicine Group, Biomedical Sciences Research Institute, Ulster University, Coleraine, BT52 1SA, Northern Ireland, UK
MetadataShow full item record
AbstractGlaucoma is a complex neurodegenerative disease resulting in progressive optic neuropathy and is a leading cause of irreversible blindness worldwide. Primary open angle glaucoma (POAG) is the predominant form affecting 65.5 million people globally. Despite the prevalence of POAG and the identification of over 120 glaucoma related genetic loci, the underlaying molecular mechanisms are still poorly understood. The transforming growth factor beta (TGF-β) signalling pathway is implicated in the molecular pathology of POAG. To gain a better understanding of the role TGF-β2 plays in the glaucomatous changes to the molecular pathology in the trabecular meshwork, we employed RNA-Seq to delineate the TGF-β2 induced changes in the transcriptome of normal primary human trabecular meshwork cells (HTM). We identified a significant number of differentially expressed genes and associated pathways that contribute to the pathogenesis of POAG. The differentially expressed genes were predominantly enriched in ECM regulation, TGF-β signalling, proliferation/apoptosis, inflammation/wound healing, MAPK signalling, oxidative stress and RHO signalling. Canonical pathway analysis confirmed the enrichment of RhoA signalling, inflammatory-related processes, ECM and cytoskeletal organisation in HTM cells in response to TGF-β2. We also identified novel genes and pathways that were affected after TGF-β2 treatment in the HTM, suggesting additional pathways are activated, including Nrf2, PI3K-Akt, MAPK and HIPPO signalling pathways. The identification and characterisation of TGF-β2 dependent differentially expressed genes and pathways in HTM cells is essential to understand the patho-physiology of glaucoma and to develop new therapeutic agents.
CitationCallaghan B, Lester K, Lane B, Fan X, Goljanek-Whysall K, Simpson DA, et al. Genome-wide transcriptome profiling of human trabecular meshwork cells treated with TGF-β2. Vol. 12, Scientific Reports. Springer Science and Business Media LLC; 2022.
- Interleukin-6-mediated trans-signaling inhibits transforming growth factor-β signaling in trabecular meshwork cells.
- Authors: Inoue-Mochita M, Inoue T, Kojima S, Futakuchi A, Fujimoto T, Sato-Ohira S, Tsutsumi U, Tanihara H
- Issue date: 2018 Jul 13
- Altered Expression of Extracellular Vesicles miRNAs from Primary Human Trabecular Meshwork Cells Induced by Transforming Growth Factor-β2.
- Authors: Zhang J, Wang Y
- Issue date: 2021 Jul
- Effects of TGF-β2 on cadherins and β-catenin in human trabecular meshwork cells.
- Authors: Wecker T, Han H, Börner J, Grehn F, Schlunck G
- Issue date: 2013 Oct 1
- Cellular fibronectin expression in human trabecular meshwork and induction by transforming growth factor-β2.
- Authors: Medina-Ortiz WE, Belmares R, Neubauer S, Wordinger RJ, Clark AF
- Issue date: 2013 Oct 17
- Crosstalk between transforming growth factor β-2 and Autotaxin in trabecular meshwork and different subtypes of glaucoma.
- Authors: Igarashi N, Honjo M, Yamagishi R, Kurano M, Yatomi Y, Igarashi K, Kaburaki T, Aihara M
- Issue date: 2021 Jun 17